Orthopedic, Prosthetic & Surgical Appliances & Supplies · SIC 3842
ESTABLISHMENT LABS HOLDINGS INC.
ESTA
Latest revenue
$59.9M
as of 2026-03-31
Latest net income
$-13.4M
as of 2026-03-31
Net margin
-22.3%
as of 2026-03-31
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $2.12B
- Enterprise value
- $2.12B
- P/E (trailing)
- —
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- 52-wk high
- $83.31
- 52-wk low
- $33.35
- Beta
- —
- Shares out
- 29.4M
5-year trend
What this company does
ITEM 1. BUSINESS Overview We are a global medical technology company focused on improving patient safety and aesthetic outcomes, initially in the breast aesthetics and reconstruction market. We initially incorporated in Costa Rica in 2004 and subsequently reorganized in 2013 under a parent holding company in the British Virgin Islands. Our line of silicone gel-filled breast implants, branded as Motiva Implants, is the centerpiece of our medical technology platform. Our 5-year results from our Motiva U.S. IDE study as well as our patient and practitioner reported post-market surveillance data indicate that Motiva Implants have low rates of adverse events (including rupture, capsular…
AI summary unavailable — showing raw filing excerpt
Generated from ESTA's filing dated 2026-02-27
Key risks
ITEM 1A. RISK FACTORS Investing in our common shares involves a high degree of risk. We operate in a rapidly changing economic and competitive environment that presents numerous risks, many of which are driven by factors that we cannot control or predict. The following risk factors describe circumstances or events that could have a negative effect on our business, financial condition or operating results. You should consider the following risks carefully, together with all the other information in this Annual Report on Form 10-K, including our consolidated financial statements and notes thereto, before you invest in our common shares. If any of the following risks occur, our business,…
AI summary unavailable — showing raw filing excerpt
Generated from ESTA's filing dated 2026-02-27
Profitability
Gross margin
69.3%
5.1%Operating margin
-18.5%
38.6%Net margin
-24.2%
52.5%Return on equity
-216.9%
52.8%Return on assets
-14.3%
41.4%Leverage
Debt / equity
14.17×
20.6%Long-term debt / equity
10.51×
11.9%Debt / assets
93.4%
1.4%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | $59.9M | +44.7% | $-13.4M | +35.4% | -22.3% |
Q4 2025 2025-12-31 | $64.6M | +45.2% | $-2.6M | +92.4% | -4.0% |
Q3 2025 2025-09-30 | $53.8M | +33.7% | $-11.1M | +33.2% | -20.7% |
Q2 2025 2025-06-30 | $51.3M | +16.3% | $-16.6M | +3.4% | -32.3% |
Q1 2025 2025-03-31 | $41.4M | +11.3% | $-20.7M | -27.8% | -50.1% |
Q4 2024 2024-12-31 | $44.5M | — | $-34.5M | — | -77.6% |
Q3 2024 2024-09-30 | $40.2M | +4.5% | $-16.7M | +43.0% | -41.5% |
Q2 2024 2024-06-30 | $44.1M | -9.2% | $-17.2M | -2.6% | -38.9% |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Orthopedic, Prosthetic & Surgical Appliances & Supplies · SIC 3842
Your notes
Keep private notes on ESTA — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$377.9K
Insider selling
$29.2M
Net activity
−$28.8M
Distinct insiders
4
Open-market trades over the last 365 days.
Recent transactions
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns ESTA
Institutional value
$446.7M
Total shares held
8.0M
Distinct holders
82
-91 vs prior
As of
2026-03-31
Prior: 2025-12-31
Filers with $100M+ AUM disclose holdings 45 days after quarter end.
Top institutional holders
| # | Manager | Shares | Value | QoQ change | Action |
|---|---|---|---|---|---|
| 1 | JW Asset Management, LLC | 3.1M | $173.8M | +0 (+0.0%) | No change |
| 2 | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 688.9K | $39.1M | +49.1K (+7.7%) | Added |
| 3 | JANE STREET GROUP, LLC | 627.7K | $35.6M | +272.2K (+76.6%) | Added |
| 4 | ROYCE & ASSOCIATES LP | 427.5K | $24.3M | +68.9K (+19.2%) | Added |
| 5 | JPMORGAN CHASE & CO | 362.9K | $19.8M | +215.5K (+146.1%) | Added |
| 6 | Nuveen, LLC | 322.7K | $18.3M | -29.4K (-8.4%) | Trimmed |
| 7 | Tejara Capital Ltd | 308.6K | $17.5M | +183.3K (+146.3%) | Added |
| 8 | FRANKLIN RESOURCES INC | 239.2K | $13.6M | +96.7K (+67.8%) | Added |
| 9 | BNP PARIBAS FINANCIAL MARKETS | 206.8K | $11.7M | +10.6K (+5.4%) | Added |
| 10 | UBS Group AG | 147.7K | $8.4M | +106.3K (+256.8%) | Added |
| 11 | Granite Investment Partners, LLC | 143.5K | $8.2M | -7.9K (-5.2%) | Trimmed |
| 12 | CenterBook Partners LP | 135.0K | $7.7M | +79.4K (+142.7%) | Added |
| 13 | BlackRock, Inc. | 127.5K | $7.2M | +6.0K (+4.9%) | Added |
| 14 | KORNITZER CAPITAL MANAGEMENT INC /KS | 116.6K | $6.6M | -2.3K (-1.9%) | Trimmed |
| 15 | Capital Research Global Investors | 102.9K | $5.8M | -704.9K (-87.3%) | Trimmed |
| 16 | DEUTSCHE BANK AG\ | 101.5K | $5.8M | -92.8K (-47.8%) | Trimmed |
| 17 | Strategic Wealth Partners, Ltd. | 58.1K | $3.3M | +3.1K (+5.6%) | Added |
| 18 | Simplify Asset Management Inc. | 53.0K | $3.0M | -19.9K (-27.3%) | Trimmed |
| 19 | VANGUARD PORTFOLIO MANAGEMENT LLC | 52.3K | $3.0M | — | New |
| 20 | Assenagon Asset Management S.A. | 51.3K | $2.9M | -64.6K (-55.7%) | Trimmed |
Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.
Top questions investors are asking
Coming once ESTA's latest filing finishes processing.